Search

Your search keyword '"Chiba, Yohei"' showing total 128 results

Search Constraints

Start Over You searched for: Author "Chiba, Yohei" Remove constraint Author: "Chiba, Yohei"
128 results on '"Chiba, Yohei"'

Search Results

3. Role of Tensor Interaction as Salvation of Cluster Structure in $^{44}$Ti

5. Unexpectedly enhanced $\alpha$-particle preformation in $^{48}$Ti probed by the $(p,p\alpha)$ reaction

6. Manifestation of the divergence between antisymmetrized-molecular-dynamics and container pictures of $^{9}$Be via ${}^{9}$Be($p,pn$)${}^{8}$Be knockout reaction

7. Neutron dominance in excited states of $^{26}$Mg and $^{10}$Be probed by proton and alpha inelastic scattering

8. Correspondence between isoscalar monopole strengths and $\alpha$ inelastic cross sections on $^{24}$Mg

9. Cluster correlation and nuclear vorticity in low-lying $1^-$ states of $^{24}$Mg

10. Quantitative description of the $^{20}$Ne($p$,$p\alpha$)$^{16}$O cross section as a means of probing the surface $\alpha$ amplitude

13. Laplace expansion method for the calculation of the reduced width amplitudes

14. A multicenter investigator-initiated Phase 2 trial of E7090 in patients with advanced or recurrent solid tumor with fibroblast growth factor receptor (FGFR) gene alteration: FORTUNE trial

15. A single-institution retrospective exploratory analysis on the effectiveness and safety of lenvatinib plus pembrolizumab for advanced endometrial cancer: insights from ProMisE molecular classification system

16. Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer.

19. PR017/#434 A phase II study of oxaliplatin with oral S-1 for patients with recurrent non-squamous cell carcinoma of uterine cervix (Tohoku gynecologic cancer unit 206 study)

22. Efficacy and Safety of Platinum-based Chemotherapy With Bevacizumab Followed by Bevacizumab Maintenance for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer During PARP Inhibitor Therapy: A Multicenter Retrospective Study

23. 2022-RA-629-ESGO Association of folate receptor α expression and tumor immune microenvironment in patients with cervical cancer

24. 2022-RA-793-ESGO TROP-2 expression and the tumor immune-microenvironment in cervical cancer

26. MO17-1 Clinical practice of comprehensive genomic profiling in gynecologic malignancies at National Cancer Center Hospital

27. P38-3 Clinical outcomes of next-generation sequencing test for breast cancer at the National Cancer Center Hospital

32. Manifestation of the divergence between antisymmetrized-molecular-dynamics and container pictures of Be via Be( , ) Be knockout reaction

33. ACT-1 Multicenter investigator-initiated registration-directed Phase 2 study of E7090 in subjects with advanced or recurrent solid tumors with fibroblast growth factor receptor (FGFR) gene alteration: FORTUNE trial

35. SYST-01. MULTICENTER INVESTIGATOR-INITIATED PHASE 2 STUDY OF E7090 IN SUBJECTS WITH ADVANCED OR RECURRENT SOLID TUMORS WITH FIBROBLAST GROWTH FACTOR RECEPTOR (FGFR) GENE ALTERATION: FORTUNE STUDY

38. MO13-5 Clinical features and prognosis of patients with unresectable locally advanced or metastatic olfactory neuroblastoma

39. O3-4 Etoposide, doxorubicin, and cisplatin with mitotane in metastatic adrenocortical carcinoma in the National Cancer Center

44. Correspondence between isoscalar monopole strengths and |$\alpha$| inelastic cross sections on 24Mg.

48. 気候変動影響: ビジネスの転換を通じた持続可能な開発に向けて

49. 銀行セクターにおける気候関連リスクの統合強化に向けて

50. Impact of climate change –transforming business behaviour in favour of sustainable development

Catalog

Books, media, physical & digital resources